Top Markets
Coin of the day
DelMar Pharmaceuticals, Inc. DelMar Pharmaceuticals, Inc.

DelMar Pharmaceuticals, Inc.

DMPWW
Rankning i aktier #42376
Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc.... Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.
Aktiekurs
$0.005
Senast synkroniserad: 2024-06-20
Marknadsvärde
$1.74K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel DelMar Pharmaceuticals, Inc. (DMPWW)

Kategori

Aktiekurshistorik för DelMar Pharmaceuticals, Inc. (DMPWW)
Högsta slutkurs: $0.00 den 2024-06-01

Lägsta slutkurs: $0.05 den 2022-01-01
Aktiekurshistorik för DelMar Pharmaceuticals, Inc. från 2022 till 2026
Årlig aktiekursutveckling
År Prestanda
2024 79.76%
2023 -86.88%
2022 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.57%
KR